Active substance
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
Therapeutical formulation
OPLOSSING

€ 16,807.80 € 16,807.80 excluding delivery costs.

This drug is not covered by your health insurance company.

Own risk

Nothing will be charged to your deductible.

Strength
1000MQ/ML
Supplier
NOVARTIS PHARMA BV
Available outside pharmacies
No
Remarks
  • This medicine is available by prescription only.
EU number
EU/1/22/1703/001